Related Experiment Videos
AMP-deaminase from normal and cirrhotic human liver: a comparative study
Paweł Dutka1, Magdalena Szydłowska, Zygmunt Chodorowski
1Department of Anesthesiology and Intensive Therapy, Debinki Medical University of Gdansk, Gdansk, Poland.
Molecular and Cellular Biochemistry
|November 10, 2004
Summary
AMP-deaminase, crucial for regulating adenine nucleotides, shows reduced sensitivity and altered kinetics in cirrhotic liver tissue. Proteolytic damage likely impairs its function and regulation in liver disease.
Area of Science:
- Biochemistry
- Enzymology
- Cellular Metabolism
Background:
- AMP-deaminase (EC 3.5.4.6) regulates the adenine nucleotide pool in mammalian cells.
- This enzyme catalyzes a rate-limiting step in adenine nucleotide catabolism within the liver.
Purpose of the Study:
- To investigate the kinetic and regulatory properties of AMP-deaminase from normal and cirrhotic human liver.
- To compare the enzyme's sensitivity to effectors and structural integrity between healthy and diseased liver tissues.
Main Methods:
- Purification of AMP-deaminase from normal and cirrhotic human liver.
- Kinetic analysis of enzyme activity and allosteric regulation.
- SDS-PAGE electrophoresis to assess protein structure.
Main Results:
- AMP-deaminase from cirrhotic liver exhibited decreased sensitivity to substrate analogues, pH, and adenylate energy charge compared to normal liver enzyme.
- Enzyme from cirrhotic liver showed higher S0.5 values and different regulatory profiles with allosteric effectors.
- SDS-PAGE revealed smaller protein fragments in cirrhotic liver AMP-deaminase, indicating proteolytic degradation.
Conclusions:
- Advanced proteolytic processes in cirrhotic liver compromise AMP-deaminase's structural integrity.
- This degradation leads to reduced enzyme activity and impaired sensitivity to regulatory effectors in liver disease.